Benchmark (BMK) full year 2021 results presentation - November 2021

Benchmark's CEO, Trond Williksen and CFO, Septima Maguire present the full year results for the period ended 30th September 2021.

Trond Williksen, CEO
00:17 – Introduction
00:52 – Highlights of the period
04:21 – Performance highlights
06:48 – Operational highlights

Septima Maguire, CFO
13:16 – Financial review
15:44 – Segmental highlights
23:07 – Cash flow
24:29 – Looking forward

Trond Williksen, CEO
26:22 – Strategy
28:23 – ‘One Benchmark’ opportunities
29:33 – Current trading & Outlook
31:07 – Investment case
31:36 – Closing remarks

Benchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The Company’s segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The Company’s products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.